The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Purpose Age‐related macular degeneration is the most common cause of blindness in the western world among elderly people. In response to anti‐VEGF treatment for wet‐AMD retinal anatomy and visual acuity is often remedied. In our previous study, we showed that also visual evoked potentials (VEP) improve following successful anti‐VEGF treatment. The aim of the present study was to investigate, if visual...
Purpose Anti‐vascular endothelial growth factor (VEGF) agents have been shown to improve visual acuity and prevent vision loss in exudative age‐related macular degeneration (AMD). As the vision improves relatively quickly in response to intravitreal injections, we wanted to know whether this improvement is reflected in electrophysiolocal markers of visual cortical processing.
Methods Our interventional...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.